REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot125910.21518/1561-5936-2018-6-16-21Original Article«May» prospects for Russian pharma marketTrofimovaЕ. О.noemail@neicon.ruSaint Petersburg State Chemical Pharmaceutical University061220186162118032022Copyright © 2018,2018The agenda of the PharmASI Russian Pharmaceutical Forum held on May 15-16, 2018 in St. Petersburg highlighted the current issues of the Russian pharmaceutical market. Today, the key issues include getting the balance of various interests of market participants and identifying the market drivers. The main issues of international companies on the Russian market are related to enforcement of intellectual property rights, which is setting in favor of Russian companies. The unfavourable economic situation in the country causes a slowdown of growth rates on the Russian pharmaceutical market. The key market driver for the period until 2024 is the national healthcare project announced in the presidential decree in May 2018.Russian pharmaceutical market and industryintellectual property protectionstate industrial policyinvestment activitylocal manufacturing contentinnovative drugspharmaceutical insuranceроссийский фармацевтический рынок и промышленностьохрана интеллектуальной собственностигосударственная промышленная политикаинвестиционная активностьлокализация производстваинновационные лекарственные препаратылекарственное страхование